(Q37581581)

21 August 2017

1 reference

title

Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions (English)

1 reference

attention deficit hyperactivity disorder

21 August 2017

main subject

0 references

1 reference

1 reference

Grazia Dell'Agnello

1

1 reference

21 August 2017

Alessandro Zuddas

2

1 reference

21 August 2017

Gabriele Masi

3

1 reference

21 August 2017

Paolo Curatolo

4

1 reference

21 August 2017

Dante Besana

5

1 reference

21 August 2017

Andrea Rossi

6

1 reference

21 August 2017

publication date

1 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

23

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

739-753

1 reference

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11314350-000000000-00000

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11314350-000000000-00000

Attention-deficit/hyperactivity disorder and associated childhood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11314350-000000000-00000

Atomoxetine-induced hepatitis in a child.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11314350-000000000-00000

Adolescent psychopathology: III. The clinical consequences of comorbidity.

21 January 2018

1 reference

12 December 2020

Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data

1 reference

12 December 2020

Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome

1 reference

12 December 2020

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

12 December 2020

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

1 reference

12 December 2020

Severe liver injury after initiating therapy with atomoxetine in two children.

1 reference

12 December 2020

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders

1 reference

12 December 2020

Diagnosing mental disorders in office-based pediatric practice

1 reference

12 December 2020

Safety profile of atomoxetine in the treatment of children and adolescents with ADHD.

1 reference

12 December 2020

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

1 reference

12 December 2020

Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview

1 reference

12 December 2020

Are childhood psychiatric histories of bipolar adolescents associated with family history, psychosis, and response to lithium treatment?

1 reference

12 December 2020

Attention deficit hyperactivity disorder in adolescent mania

1 reference

12 December 2020

Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups

1 reference

12 December 2020

Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study

1 reference

12 December 2020

A prospective study of teachers' ratings of behavior problems in children with new-onset seizures

1 reference

12 December 2020

Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

New options in the pharmacological management of attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

1 reference

12 December 2020

Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome

1 reference

12 December 2020

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents

1 reference

12 December 2020

Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence

1 reference

12 December 2020

Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder

1 reference

12 December 2020

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

12 December 2020

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Meta-analysis of suicide-related behavior events in patients treated with atomoxetine

1 reference

12 December 2020

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

1 reference

12 December 2020

Prevalence of ADHD and comorbid disorders among elementary school children screened for disruptive behavior

1 reference

12 December 2020

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder

1 reference

12 December 2020

ADHD and epilepsy in childhood

1 reference

12 December 2020

Is comorbidity with ADHD a marker for juvenile-onset mania?

1 reference

12 December 2020

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

1 reference

12 December 2020

Cardiovascular effects of atomoxetine in children, adolescents, and adults

1 reference

12 December 2020

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

1 reference

12 December 2020

Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine

1 reference

12 December 2020

Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.

1 reference

12 December 2020

Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications

1 reference

12 December 2020

DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls

1 reference

12 December 2020

Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study

1 reference

12 December 2020

Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder

1 reference

12 December 2020

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

12 December 2020

Attention deficit disorder and epilepsy

1 reference

12 December 2020

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

1 reference

12 December 2020

The comorbidity of ADHD in the general population of Swedish school-age children.

1 reference

12 December 2020

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

1 reference

12 December 2020

Seizures and prolonged QTc with atomoxetine overdose

1 reference

12 December 2020

Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.

1 reference

12 December 2020

Impact of comorbid oppositional or conduct problems on attention-deficit hyperactivity disorder

1 reference

12 December 2020

Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder

1 reference

12 December 2020

Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.

1 reference

12 December 2020

1 reference

12 December 2020

Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders

1 reference

12 December 2020

Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study

1 reference

12 December 2020

Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.

1 reference

12 December 2020

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

12 December 2020

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

12 December 2020

Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder

1 reference

12 December 2020

Co-existing psychiatric problems in ADHD in the ADORE cohort.

1 reference

12 December 2020

ADHD as a risk factor for incident unprovoked seizures and epilepsy in children.

1 reference

12 December 2020

Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents.

1 reference

12 December 2020

Assessment and diagnosis of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Effects of atomoxetine and methylphenidate on sleep in children with ADHD.

1 reference

12 December 2020

Prevalence of child and adolescent psychiatric disorders: the Zürich Epidemiological Study.

1 reference

12 December 2020

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

1 reference

12 December 2020

Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Atomoxetine ingestions in children: a report from poison centers

1 reference

12 December 2020

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders

1 reference

12 December 2020

Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder

1 reference

12 December 2020

Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).

1 reference

12 December 2020

Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.

1 reference

12 December 2020

The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity

1 reference

12 December 2020

Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder

1 reference

12 December 2020

Atomoxetine and tics in ADHD.

1 reference

12 December 2020

Abdominal Tics During Atomoxetine Treatment in a Child With ADHD: Evaluation and Differential Diagnosis.

1 reference

12 December 2020

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder

1 reference

12 December 2020

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

12 December 2020

Comorbidity with ADHD decreases response to pharmacotherapy in children and adolescents with acute mania: evidence from a metaanalysis

1 reference

12 December 2020

Premorbid functioning in adolescent onset bipolar I disorder: a preliminary report from an ongoing study

1 reference

12 December 2020

Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

1 reference

12 December 2020

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

1 reference

12 December 2020

10.2165/11314350-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1006521570

0 references

1 reference